MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
Sector:
Process Industries
Industry:
Agricultural Commodities Or Milling
Employees:
166
Frequently Asked Questions
What is Market Cap of Medipharm Labs Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medipharm Labs Corp market cap is $23.84M.
What is the 52-week high for Medipharm Labs Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medipharm Labs Corp 52 week high is $0.0769 as of June 05, 2024.
What is the 52-week low for Medipharm Labs Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medipharm Labs Corp 52 week low is $0.04 as of June 05, 2024.
What is Medipharm Labs Corp stock price today?
Medipharm Labs Corp stock price today is $0.0589.
What was Medipharm Labs Corp stock price yesterday?
Medipharm Labs Corp stock price yesterday was $0.0561.
What is the PE ratio of Medipharm Labs Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medipharm Labs Corp’s P/E ratio is -2.34.
What is the Price-to-Book ratio of Medipharm Labs Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medipharm Labs Corp P/B ratio is 0.6460.
What is Medipharm Labs Corp's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Medipharm Labs Corp's EBITDA is -1.05.
What is the 50-day moving average of Medipharm Labs Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medipharm Labs Corp 50-day moving average is $0.0609.